The Indian Journal of Pediatrics

, Volume 62, Issue 5, pp 507–518 | Cite as

Hepatitis C in childhood

  • Flavia Bortolotti
Symposium: Hepatology—Part I
  • 18 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Choo QL, Kuo G, Weiner AJ et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science 1989; 244: 359–362.PubMedCrossRefGoogle Scholar
  2. 2.
    Kuo G, Choo QL, Aler HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science 1989; 244: 362–364.PubMedCrossRefGoogle Scholar
  3. 3.
    Houghton M, Weiner A, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implication for diagnosis, development and control.Hepatology 1991; 14: 381–388.PubMedGoogle Scholar
  4. 4.
    Genesca J, Esteban JI, Alter HJ. Blood-borne non-A, non-B hepatitis: hepatitis C.Semin Liver Dis 1991; 11: 147–164.PubMedGoogle Scholar
  5. 5.
    Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.N Engl J Med 1989; 321; 1494–1500.PubMedCrossRefGoogle Scholar
  6. 6.
    Alter MJ, Margolis Hf, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States.New Engl J Med 1992; 327: 1899–1905.PubMedCrossRefGoogle Scholar
  7. 7.
    Bortolotti F, Tagger A, Cadrobbi Pet al. Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis.J Hepatol 1991; 12: 176-a80.PubMedCrossRefGoogle Scholar
  8. 8.
    Alter HJ. Chronic consequences of non-A, non-B hepatitis. In Seef LB, Lewis JH ed:Current Perspectives in Hepatology, New York: Plenum Publishing, 1989: 83–97.Google Scholar
  9. 9.
    Saito I, Miyamura T, Ohbayashi A et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proc Natl Acad Sci 1990; 87: 6547–6549.PubMedCrossRefGoogle Scholar
  10. 10.
    Hoofnagle JH, Di Bisceglie AM, Shindo M. Antiviral therapy of hepatitis C-present and future.J Hepatol 1993; 17 (Suppl. 3): 130–136.CrossRefGoogle Scholar
  11. 11.
    Alberti A, Chemello L, Bonetti P et al. Treatment with interferon (s) of community-acquired chronic hepatitis and cirrhosis type C.J Hepatol 1993; 17: (Supple. 3): 123–126.CrossRefGoogle Scholar
  12. 12.
    Van der Peol CL, Cuypers HTM, Reesink HW et al. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay.Lancet 1991; 337: 317–319.CrossRefGoogle Scholar
  13. 13.
    Lelie PN, Cuypers HTM, Reesink HW et al. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assay.J Med Viro 1992; 37: 202–209.Google Scholar
  14. 14.
    Chemello L, Cavalletto L, Pontisso P et al. Patterns of antibodies ot hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.Hepatology 1993; 17: 179–182.PubMedGoogle Scholar
  15. 15.
    Bortolotti F, Vajro P, Barbera C et al. Patterns of antibodies to hepatitis C virus and hepatitis C virus replication in children with chronic non-A, non-B hepatitis.J Pediatr 1994; 125.Google Scholar
  16. 16.
    Lai ML, De virgilis S, Argiolu F et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of post-transfusion hepatitis among thalassemic children: Comparison, between first and second generation assay.J Pediatr Gastroenterol Nutr 1993; 16: 458–464.PubMedGoogle Scholar
  17. 17.
    Chicheportiche C, Cantaloube JF, Biagnini P et al. Analysis of ELISA hepatitis C virus-positive blood donors popultion by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.Acta Virology 1993; 37: 123–131.Google Scholar
  18. 18.
    Brillanti S, Masci C, Ricci P et al. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.Hepatology 1992; 15: 998–1001.PubMedCrossRefGoogle Scholar
  19. 19.
    Lok ASF, Cheung R, Chan R, Liu V. Hepatitis C viremia in patients with hepatitis C virus infection.Hepatology 1992; 15: 1007–1012.PubMedCrossRefGoogle Scholar
  20. 20.
    Farci P, Alter H, Wong D et al. A longterm study of hepatitis C virus replication in non-A, non-B hepatitis.N Engl J Med 1991; 325: 98–104.PubMedCrossRefGoogle Scholar
  21. 21.
    Davis GL, Lau JYN, Urdea MS et al. Quantitative detection of hepatitis C virus (HCV) RNA by a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.Hepatology 1994; 19: 1337–1341.PubMedGoogle Scholar
  22. 22.
    Magrin S, Craxi A, Fabiano C et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment:Hepatology 1994; 19: 273–279.PubMedGoogle Scholar
  23. 23.
    Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes.Hepatology 1994; 19: 1321–1324.PubMedCrossRefGoogle Scholar
  24. 24.
    Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.Hepatology 1992; 16: 293–299.PubMedCrossRefGoogle Scholar
  25. 25.
    Tanaka E, Kiyosawa K, Sodeyama T et al. Prevalence of antibody to hepatisi C virus in Japanese schoolchildren: comparison with adult blood donors.Am J Trop Med Hyg 1992; 46: 460–464.PubMedGoogle Scholar
  26. 26.
    Change MH, Lee CY, Chen DS. Minimal role of hepatitis C virus infection in childhood liver disease in an area hyperendemic for hepatitis B virus infection.J Med Viron 1993; 40: 322–325.CrossRefGoogle Scholar
  27. 27.
    Thuring EG, Joller-Jemelka HI, Sareth H et al. Prevalence of markers of hepatitis A, B, C and of HIV in healthy individuals and patients of a Cambodian province.Southeast Asian J Trop Med Public Health 1992; 24: 239–249.Google Scholar
  28. 28.
    Ngatchu T, Stroffolini T, Rapicetta M et al. Seroprevalence of anti-HCV in an urban children population: as pilot survey in a developing area, Cameroon.J Trop Med Hyg 1992; 95: 57–61.PubMedGoogle Scholar
  29. 29.
    Al-Faleh FZ, Ayoola EA, Al-Jeffry M et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study.Hepatology 1991; 14: 215–218.PubMedCrossRefGoogle Scholar
  30. 30.
    Aceti A, Taliani G, Bruni R et al. Hepatitis C virus infection in chronic liver disease in Somalia.Am J Trop Med Hyg 1993; 48: 581–584.PubMedGoogle Scholar
  31. 31.
    Romano L, Azara A, Chiaramonte M et al. Low prevalence and anti-HCV antibody among Italian children.Infection 1994; 22: 350–352.PubMedCrossRefGoogle Scholar
  32. 32.
    Bortolotti F, Calzia R, Vegnente A et al. Chronic hepatitis in childhood: The spectrum of the disease.Gut 1988; 29: 659–664.PubMedCrossRefGoogle Scholar
  33. 33.
    Bortolotti F, Jara P, Diaz C et al. Posttransfussion and community-acquired hepatitis C in childhood.J Pediatr Gastroenterol Nutr 1994; 18: 279–283.PubMedGoogle Scholar
  34. 34.
    Iorio R, Guida, S, Porzio S, Fariello I, Vegnente A. Chronic non-A, non-B hepatitis: role of hepatitis C virus.Arch Dis Child 1993; 68: 219–222.PubMedGoogle Scholar
  35. 35.
    Hsu SC, Chang MH, Chen DS et al. Non-A, non-B hepatitis in children: a clinical, histologic, and serologic study.J Med Virol 1991; 35: 1–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Blanchette VS, Vorstman E, Shore A et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 78: 285–289.PubMedGoogle Scholar
  37. 37.
    Kanesaki T, Kinoshita S, Tsujino G et al. Hepatisi C virus infection in children with hemophilia; characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.J Pediatr 1993; 123: 381–387.PubMedCrossRefGoogle Scholar
  38. 38.
    Resti M, Azzari C, Rossi ME, Vullo C et al. Hepatitis C virus antibodies in a longterm follow-up of beta-thalassemic children with acute and chronic non-A, non-B hepatitis.Eur J Pediatr 1992; 151: 573–576.PubMedCrossRefGoogle Scholar
  39. 39.
    Locasciulli A, Gornati G, Tagger A et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission.Blood 1991; 78: 1619–1622.PubMedGoogle Scholar
  40. 40.
    Fink FM, Hoecker-Schulz S, Mor W et al. Assocaition of hepatitis C virus infection with chronic liver disease in paediatric cancer patients.Eur J Pediatr 1992; 152: 490–492.CrossRefGoogle Scholar
  41. 41.
    Puchhammer-Stoeckl E, Hofmann H, Fink FM et al. Prevalence of hapatitis C virus infection in children with chronic post-transfusion hepatis.J. Med Virol 1992; 37: 298–302.CrossRefGoogle Scholar
  42. 42.
    Jonas MM, Zilleruelo GE, La Rue SI et al. Hepatitis C infection in a pediatric dialysis populationPediatrics 1992; 89: 707–709.PubMedGoogle Scholar
  43. 43.
    Ni YH, Chang MH, Lue HC et al. Posttransfussion hepatitis C virus infection in children.J Pediatr 1994; 124: 709–713.PubMedCrossRefGoogle Scholar
  44. 44.
    Keller KM, Wirth S. Low incidence of hepatitis C virus (HCV) infection in preterms and newborns after polytranfusion.Monatsschrift Kinderheilkunde 1992; 140: 108–112.PubMedGoogle Scholar
  45. 45.
    Locasciulli A, Cavalletto D, Pontisso P et al. Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy.Blood 1993; 82: 2564–2567.PubMedGoogle Scholar
  46. 46.
    Dussaix E, de Paillette L, Laurent-Puig P et al. Hepatitis C virus infection in pediatric liver transplantation.Transplantation 1993; 55: 795–798.PubMedCrossRefGoogle Scholar
  47. 47.
    Pastore M, Willems M, Cornu C et al. Prevalence, diagnosis and clinical course of chronic hepatitis C following liver transplantation in children.Hepatology 1994; 20: 4: 132A.Google Scholar
  48. 48.
    Inoue Y, Miyamura T, Unayama T, Takahashi K, Saito I. Maternal transfer of HCV.Nature 1991; 353: 609.PubMedCrossRefGoogle Scholar
  49. 49.
    Novati R, Thiers V, d’Arminio Monforte A et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.J Infect Dis 1992; 165: 720–723.PubMedGoogle Scholar
  50. 50.
    Nagata I, Shiraki K, Tanimoto K et al. Mother-to-infant transmission of hepatitis C virus.J Pediatr 1992; 120: 432–334.PubMedCrossRefGoogle Scholar
  51. 51.
    Weiner AJ, Thaler MM, Crawford K et al. A uninique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants.J. Virol 1993; 67: 4365–4368.PubMedGoogle Scholar
  52. 52.
    Ohto H, Terazawa S, Sasaki N et al. Transmission of hepatitis C virus from mothers to infants.N Engl J Med 1994; 330: 744–750.PubMedCrossRefGoogle Scholar
  53. 53.
    Roudot-Thoraval F, Pawlotsky JM, Thiers V et al. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.Hepatology 1993; 17: 772–777.PubMedGoogle Scholar
  54. 54.
    Ercilla MG, Fortuny C, Roca A et al. Mother to infant transmission of hepatitis C virus. Proceedings 4th Internatl symp on HCV, Tokyo 1993: 31.Google Scholar
  55. 55.
    Lam JPH, McOmish F, Burns SM et al. Infrequent vertical transmission of hepatitis C virus.J Infect Dis 1993; 167: 572–576.PubMedGoogle Scholar
  56. 56.
    Giovannini M, Tagger A, Ribero ML et al. Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction.Lancet 1990; 335: 1166.PubMedCrossRefGoogle Scholar
  57. 57.
    Weintrub PS, Veereman-Wauters G, Cowan MJ, Thaler M. Hepatitis C virus infection in infants whose mothers took street drugs intravenously.J Pediatr 1991; 119: 869–874.PubMedCrossRefGoogle Scholar
  58. 58.
    Camarero C, Martos I, Delgado R et al. Horizontal transmission of heaptitis C virus in households of infected children.J Pediatr 1993; 123: 98–99.PubMedCrossRefGoogle Scholar
  59. 59.
    Buscarini E, Tanzi E, Zanetti A et al. High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-postive chronic liver disease. Scand J Gastroenterol 1993; 28: 343–346.PubMedCrossRefGoogle Scholar
  60. 60.
    Napoli N, Fiore G, Vella F, Fera G, Schiraldi O. Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C.Eur J Epidemiol 1993; 9: 629–632.PubMedCrossRefGoogle Scholar
  61. 61.
    Bortolotti, F, Cadrobbi P, Armigliato M, et al. Actue, non-A, non-B hepatitis in childhood.J Pediatr Gastroenterol Nutr 1988; 7: 22–26.PubMedCrossRefGoogle Scholar
  62. 62.
    Bortolotti F, Tagger A, Cardrobbi P et al. Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis.Lancet 1989; 2: 1162.PubMedCrossRefGoogle Scholar
  63. 63.
    Wejstal R, Hermodsson S, Iwarson S, Norkrans G. Mother to infant transmission of hepatitis C virus infection.J Med Virol 1990; 30: 178–180.PubMedCrossRefGoogle Scholar
  64. 64.
    Thaler MM, Park CK, Landers DV et al. Vertical transmission of hepatitis C virus.Lancet 1991; 338: 17–18.PubMedCrossRefGoogle Scholar
  65. 65.
    Bortolotti F, Vajro P, Cadrobbi P et al. Cryptogenic chronic liver disease and hepatitis C virus infection in children.J Hepatol 1992 15: 73–76.PubMedCrossRefGoogle Scholar
  66. 66.
    Wagner N, Rotthauwe HW. Hepatitis C contributes to liver disease in children and adolescents with hemophilia.Klin Pedaitr 1994; 206: 40–44.CrossRefGoogle Scholar
  67. 67.
    Locasciulli A, Alberti A. Hepatitis C virus serum markers and liver disease in children with leukemia.Leuk Lymphoma 1994.Google Scholar
  68. 68.
    Dibenedetto SP, Ragusa R, Sciacca A et al. Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia.Eur J Pediatr 1994; 153: 271–275.PubMedGoogle Scholar
  69. 69.
    Ruiz-Moreno M, Rua MJ, Castillo I et al. Treatment of children with chronic hepatitis C with recombinant interferonalpha: a pilot study.Hepatol 1992; 16: 882–885.CrossRefGoogle Scholar
  70. 70.
    Bortolotti F, Vijro P, Giacchino R et al. IFN treatment of chronic heaptitis C in childhood.J Hepatol 1994; 21 (suppl. 1): 68.Google Scholar
  71. 71.
    Clemente MG, Congia M, Lai ME et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.J Pediatr 1994; 125: 123–128.PubMedCrossRefGoogle Scholar
  72. 72.
    Cesaro S, Rossetti F, De Moliner L et al. Interferon for chronic hepatitis C in patients cured of malignancy.Eur J Pediatr 1994; 153: 659–662.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1995

Authors and Affiliations

  • Flavia Bortolotti
    • 1
  1. 1.Clinica Medica 2University of PaduaPaduaItaly

Personalised recommendations